Editorial: Ghost writers, vested interest and funding disclosures

Climacteric

Volumn 13, Issue 4, 2010, Pages 301-302

  Maclennan, Alastair ^a   Sturdee, David ^a   Fenton, Anna ^a   Panay, Nick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLIMACTERIUM; CLINICAL PRACTICE; EDITORIAL; ETHICS; HUMAN; MEDICAL PROFESSION; PRIORITY JOURNAL; PUBLICATION; WRITING; CONFLICT OF INTEREST; DRUG INDUSTRY; INTERPERSONAL COMMUNICATION; PUBLISHING;

AUTHORSHIP; CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; EDITORIAL POLICIES; PERIODICALS AS TOPIC;

EID: 77953607010     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.492983     Document Type: Editorial

References (6)

1. http://dida.library.ucsf.edu
2. Barbour V. How ghost-writing threatens the credibility of medical knowledge and medical journals. Haematologia 2010;95:1-2
3. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary and ghost authors in peer-reviewed medical journals. JAMA 1998;280:222-224
4. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer reviewed publications. Curr Med Res Opin 2005;21:317-321 (Pubitemid 40469909)
5. Ross JS, Hill KP, Egilman DS, et al. Guest authorship and ghostwriting in publications related to Rofecoxib: a case study of industry documents from Rofecoxib litigation. JAMA 2008;299:1800-1812
6. Sismondo S, Doucet M. Publication ethics and the ghost management of medical publication. Bioethics 2009 Feb 10. E pub ahead of print